Corinne Vandermeulen

Recombinant gp350 Vaccine for Infectious Mononucleosis: A Phase 2, Randomized, Double‐Blind, Placebo‐Controlled Trial to Evaluate the Safety, Immunogenicity, and Efficacy of an Epstein‐Barr Virus Vaccine in Healthy Young Adults

Étienne Sokal, Karel Hoppenbrouwers, Corinne Vandermeulen et al. · The Journal of Infectious Diseases · 2007 · 424 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +15

Sexual maturation in relation to polychlorinated aromatic hydrocarbons: Sharpe and Skakkebaek's hypothesis revisited.

Elly Den Hond, Harry A. Roels, Karel Hoppenbrouwers et al. · Environmental Health Perspectives · 2002 · 224 citations · Full text

Pharmacy, Environmental Sciences, Toxicology +16

A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate

Lorena Sánchez-Felipe, Thomas Vercruysse, Sapna Sharma et al. · Nature · 2020 · 191 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Outbreak of mumps in a vaccinated child population: a question of vaccine failure?

Corinne Vandermeulen, Mathieu Roelants, Marijke Vermoere et al. · Vaccine · 2004 · 124 citations

Veterinary Medicine, Infectious Diseases, Pediatrics +14

An Adjuvanted, Low‐Dose, Pandemic Influenza A (H5N1) Vaccine Candidate Is Safe, Immunogenic, and Induces Cross‐Reactive Immune Responses in Healthy Adults

Karin Levie, Isabel Leroux‐Roels, Karel Hoppenbrouwers et al. · The Journal of Infectious Diseases · 2008 · 118 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17